Merve Ozkaya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Merve Ozkaya has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Elif Sibel Aslan
Biruni University
1 shared publication - Eren Canbolat
Department of Nutrition and Dietetics, Faculty of Health Sciences, Ankara University, Ankara, Türkiye
1 shared publication - Esma Gokcen Alper Acar
Epigenetic Coaching, London SW10 9EL, UK
1 shared publication - Gulsen Meral
Epigenetic Coaching, London SW10 9EL, UK
1 shared publication - Neval Burkay
Epigenetic Coaching, London SW10 9EL, UK
1 shared publication
Latest Publications
- 11 July 2026
- Published by Springer Nature in Current Nutrition Reports
- Vol. 15 (1) , 60
Nutrigenetic Markers Related to Nutrient Metabolism, Recovery, and Performance in Athletes: a Review of Current Evidence
Purpose of Review This review aimed to evaluate current evidence regarding genetic markers associated with athletic performance, recovery, injury susceptibility, nutrient metabolism, responsiveness to ergogenic aids, and dietary behaviour in athletes. Recent Findings Classical candidate-gene studies and contemporary genome-wide investigations have identified numerous genetic variants associated with power and endurance performance, skeletal muscle capillarization, cardiac adaptation, energy metabolism, and injury susceptibility. Variants related to carbohydrate, fat, and branched-chain amino acid metabolism may contribute to inter-individual differences in substrate utilization and exercise responses. Genetic markers associated with iron, folate, and vitamin D metabolism, as well as variants influencing caffeine metabolism and sensitivity, are also relevant to sports nutrigenetics. However, differences in sample characteristics, ancestry, sport discipline, and exercise protocols limit the consistency and generalizability of the available findings. Summary Athletic performance and nutritional responses are polygenic and multifactorial traits. Therefore, no single genetic variant should be considered an independent determinant of performance capacity or nutritional requirements. Genetic information should be interpreted together with dietary intake, biochemical indicators, training characteristics, clinical status, and individual tolerance. Current evidence remains insufficient to support the routine use of nutritional or supplementation strategies based solely on genotype.
- 11 July 2026
- Published by Springer Nature in Current Nutrition Reports
- Vol. 15 (1) , 60
Nutrigenetic Markers Related to Nutrient Metabolism, Recovery, and Performance in Athletes: a Review of Current Evidence
Purpose of Review This review aimed to evaluate current evidence regarding genetic markers associated with athletic performance, recovery, injury susceptibility, nutrient metabolism, responsiveness to ergogenic aids, and dietary behaviour in athletes. Recent Findings Classical candidate-gene studies and contemporary genome-wide investigations have identified numerous genetic variants associated with power and endurance performance, skeletal muscle capillarization, cardiac adaptation, energy metabolism, and injury susceptibility. Variants related to carbohydrate, fat, and branched-chain amino acid metabolism may contribute to inter-individual differences in substrate utilization and exercise responses. Genetic markers associated with iron, folate, and vitamin D metabolism, as well as variants influencing caffeine metabolism and sensitivity, are also relevant to sports nutrigenetics. However, differences in sample characteristics, ancestry, sport discipline, and exercise protocols limit the consistency and generalizability of the available findings. Summary Athletic performance and nutritional responses are polygenic and multifactorial traits. Therefore, no single genetic variant should be considered an independent determinant of performance capacity or nutritional requirements. Genetic information should be interpreted together with dietary intake, biochemical indicators, training characteristics, clinical status, and individual tolerance. Current evidence remains insufficient to support the routine use of nutritional or supplementation strategies based solely on genotype.
- Open Access
- 17 April 2026
- Published by EUCHEMBIOJ Publishing Platform in Euchembioj Reviews
- p. e26005
The effects of green tea and curcumin on COMT and MAO pathways in nutrigenetics-based epigenetic approaches: Clinical benefits and the balanced management of psycho-oncological risks
The worldwide prevalence of all cancer types continues to rise. In this context, the psychological burden of cancer—particularly anxiety and depression—has emerged as a critical yet frequently overlooked component of comprehensive oncological care. In addition to clinical and psychosocial factors, growing evidence suggests that epigenetic mechanisms significantly influence both cancer biology and mental health, indicating that gene-environment interactions may affect psychological vulnerability in oncology contexts. Nutrigenetics-based epigenetic approaches enable personalized dietary and nutraceutical interventions based on individual genetic variability. Green tea catechins and curcumin are widely used bioactive compounds due to their epigenetic and anticancer potential. However, by altering the activity of catechol-O-methyltransferase (COMT) and monoamine oxidase (MAO), important enzymes that degrade dopamine, norepinephrine, and serotonin, these substances have an impact on monoaminergic neurotransmission. Functional polymorphisms in the COMT and MAO genes may lead to substantial interindividual differences in mood regulation, stress responsiveness, and anxiety susceptibility. This review addresses molecular, clinical, and psycho-oncological aspects of the effects of green tea and curcumin on COMT and MAO pathways within a nutrigenetics-based epigenetic nutrition framework. The findings emphasize that the potential clinical benefits of epigenetically active nutraceuticals should be evaluated through a genotype-guided, individualized, and balanced approach.
- 17 April 2026
- Published by EUCHEMBIOJ Publishing Platform in Euchembioj Reviews
- p. e26005
Open AccessThe effects of green tea and curcumin on COMT and MAO pathways in nutrigenetics-based epigenetic approaches: Clinical benefits and the balanced management of psycho-oncological risks
The worldwide prevalence of all cancer types continues to rise. In this context, the psychological burden of cancer—particularly anxiety and depression—has emerged as a critical yet frequently overlooked component of comprehensive oncological care. In addition to clinical and psychosocial factors, growing evidence suggests that epigenetic mechanisms significantly influence both cancer biology and mental health, indicating that gene-environment interactions may affect psychological vulnerability in oncology contexts. Nutrigenetics-based epigenetic approaches enable personalized dietary and nutraceutical interventions based on individual genetic variability. Green tea catechins and curcumin are widely used bioactive compounds due to their epigenetic and anticancer potential. However, by altering the activity of catechol-O-methyltransferase (COMT) and monoamine oxidase (MAO), important enzymes that degrade dopamine, norepinephrine, and serotonin, these substances have an impact on monoaminergic neurotransmission. Functional polymorphisms in the COMT and MAO genes may lead to substantial interindividual differences in mood regulation, stress responsiveness, and anxiety susceptibility. This review addresses molecular, clinical, and psycho-oncological aspects of the effects of green tea and curcumin on COMT and MAO pathways within a nutrigenetics-based epigenetic nutrition framework. The findings emphasize that the potential clinical benefits of epigenetically active nutraceuticals should be evaluated through a genotype-guided, individualized, and balanced approach.